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ABSTRACT 
Anticoagulant rodenticides (ARs) are compounds commonly used to control 
rodent pests by inhibiting an enzyme critical for synthesis of clotting factors in their 
blood. Secondary and tertiary poisoning of non-target species frequently occur, especially 
of predators that consume rodents, including many species of raptors. Although raptor 
exposure to ARs has been documented on at least three continents, patterns, pathways 
and the sub-lethal effects of exposure are not well studied. This has created a substantial 
need to monitor the effects of ARs in free-living populations. I evaluated the prevalence 
of secondary, non-target exposure to anticoagulant rodenticides experienced by a 
predatory raptor, and I tested the performance and suitability of technology originally 
developed for human patients taking oral anticoagulant drugs as a novel way to rapidly 
assay for AR exposure in free-living raptors.  
To assess the risk of ARs to birds of prey in the western United States, I surveyed 
ferruginous hawk nestlings (Buteo regalis) in Idaho, Wyoming and Colorado. These 
hawks inhabit shrub steppes, grasslands, and deserts, many of which are modified by 
agriculture, wind power, and oil and gas development. Rodenticides are often deployed in 
or near developed areas to reduce numbers of burrowing mammals. Targeted species 
include ground squirrels (Urocitellus spp.) and prairie dogs (Cynomys spp.), which often 
compose a large proportion of ferruginous hawk diet. I evaluated the prevalence and 
concentrations of eight different ARs from 173 blood samples from ferruginous hawk 
nestlings at 60 nest sites in 2018 and 2019. I also collected 117 citrated plasma samples 
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and analyzed them for biomarkers of AR exposure and indicators of sample quality: 
prothrombin time (PT), thrombin time (TCT), and fibrinogen concentration. To elucidate 
possible exposure pathways, I collected and analyzed 54 liver samples from hawk prey 
and four livers from opportunistically collected dead hawks. There were no ARs detected 
in any hawk blood or livers, but brodifacoum was present in one rodent liver at a minute 
concentration (0.003 ppm). Prothrombin time (PT) of 117 hawk nestlings averaged 29.8 
± 4.8 (SD) seconds (range: 21.3 – 41.2 sec). Sex was a strong predictor of PT, with 
female nestlings exhibiting longer PT. These findings aid in understanding the risk of AR 
exposure of ferruginous hawk nestlings in Idaho, Wyoming and Colorado and contribute 
important baseline information on PT of wild birds. 
I also evaluated the potential of a point-of-care device, the Coag-Sense® PT/INR 
Monitoring System manufactured by CoaguSense Inc. (Fremont, California), to rapidly 
detect AR exposure in living birds of prey. The Coag-Sense® device delivered repeatable 
(i.e., precise) PT measurements on avian blood samples collected from four species of 
migrating raptors (Intraclass Correlation Coefficient > 0.9). However, PT measurements 
reported by the Coag-Sense system from 81 ferruginous hawk (Buteo regalis) nestlings 
were not correlated (r = -0.017) to those measured by standardized laboratory techniques 
(i.e., the accuracy of the Coag-Sense® was low). The Coag-Sense® device therefore did 
not accurately measure PT in this species of bird and is unlikely to do so in other birds of 
prey, perhaps because it uses mammalian rather than avian thromboplastin as an activator 
of clotting. However, this device has potential use on non-human mammals.  
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THESIS INTRODUCTION 
Rodents have associated with humans since as early as the Neolithic era (van den 
Brink et al., 2018). They are seen as pests because of their effects on food and 
agricultural crops, their ability to act as reservoirs of disease, and their potential to 
damage human structures (van den Brink et al., 2018). Chemical compounds to reduce 
rodent populations (rodenticides) have been used for more than a century, and they 
remain in heavy use (Buckle and Smith, 2015; van den Brink et al., 2018). Anticoagulant 
rodenticides (ARs), or compounds that prevent blood from clotting, are the most 
commonly selected method to reduce commensal pests (van den Brink et al., 2018). 
After the discovery of the hemorrhagic properties of dicoumarol in the 1940s, 
numerous synthetic analogs were developed and registered for use (Hadler and Buckle, 
1992; Duxbury and Poller, 2001). In 1952, the drug warfarin was the first of the analogs 
to be registered as a rodenticide, and it quickly became the main compound used for 
rodent control (Duxbury and Poller, 2001). ARs work in the liver by competitively 
inhibiting an enzyme that is essential to the clotting factor synthesis cycle (Hadler and 
Buckle, 1992; Duxbury and Poller, 2001). This cycle starts with vitamin K, which is used 
to produce blood clotting factors II, VII, IX, and X through gamma-carboxylation. 
Afterwards, vitamin K is left in the inactive form, 2,3-epoxide. The epoxide reductase 
enzyme then reactivates 2,3-epoxide into the active form, allowing clotting synthesis to 
continue (Hadler and Buckle, 1992). When ARs are present, epoxide reductase enzyme 
activity is inhibited, hindering the recycling of vitamin K, thus critically reducing clotting 
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factor levels until hemorrhaging ensues (Hadler and Buckle, 1992). Because of this mode 
of action, there is a time delay between when animals ingest the AR and when toxicity 
occurs. In the case of accidental poisoning, the effects of AR can be reversed via 
treatment with supplemental vitamin K (Hadler and Buckle, 1992). Moreover, bait-shy 
rodents do not experience distressing symptoms after initially ingesting the toxicant, 
ensuring that they feed repeatedly on the bait, and eventually allowing for a lethal dose to 
be consumed (Hadler and Buckle, 1992). Additionally, poisoning with ARs was once 
seen as relatively humane (Rowsell et al., 1979), though that perception has changed in 
recent years (Littin et al., 2014). 
There are two major groups of ARs that are delineated by their chemical 
structure: hydroxycoumarins and indandiones (Valchev et al., 2008). Hydroxycoumarins 
have a 4-hydroxycoumarin ring with a side chain group attached to the 3-position, 
whereas indandiones have a 1,3 indanedione structure with a side chain group attached at 
the 2-position (Murphy and Lugo, 2015). Hydroxycoumarin compounds are more 
commonly employed and include coumachlor, coumafuryl, coumatetralyl, warfarin, 
brodifacoum, bromadiolone, difencoum, difethialone and flocoumafen (Valchev et al., 
2008). Indandione compounds include chlorophacinone, diphacinone, pindone and 
valone (Valchev et al., 2008). These rodenticides are further classified as either “first 
generation anticoagulant rodenticides” (FGARs), which are older and require multiple 
doses to be lethal, or “second-generation anticoagulant rodenticides” (SGARs), which are 
newer and only need a single-dose or “single-feed” to be effective (Valchev et al., 2008; 
van den Brink et al., 2018). FGARS include warfarin, pindone, coumafuryl, coumachlor, 
isovaleryl indanedione, chlorophacinone, and diphacinone and represent the initial ARs 
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developed. Because of heavy use of ARs beginning in the 1950’s, rodents built up a 
resistance to the original FGAR analogs, so effectiveness waned; thus, new SGAR 
derivatives were developed (Buckle and Smith, 2015). SGARs are all hydroxycoumarin 
compounds and include bromadiolone, difenacoum, brodifacoum, flocoumafen, and 
difethialone (Valchev et al., 2008; van den Brink et al. 2018). In comparison to FGARs, 
SGAR compounds have higher overall potency, a greater affinity for liver binding sites, 
and a longer half-life in animal tissues (Eason et al., 2010; Laakso et al., 2010). 
Worldwide, SGARs are now the most widely used chemicals for rodent control (Buckle 
and Smith, 2015).  
Such heavy and widespread use of ARs, especially SGARs, has led to heightened 
concerns about hazards to non-target wildlife. In fact, this use has frequently led to the 
unintentional exposures of non-target animals, especially raptors, belonging to numerous 
taxa and in widely distributed geographic locales, including New Zealand, Malaysia, 
Africa, Denmark, Norway, France, Spain, the United Kingdom, and North America 
(Salim et al., 2014; Nakayama et al., 2019; Serieys et al., 2019). Most commonly, non-
target wildlife is exposed by directly consuming bait containing anticoagulant 
rodenticides; this is called primary exposure (Valchev et al., 2008). Another route is the 
ingestion of contaminated prey (dead or alive), called secondary exposure, which is likely 
how raptors encounter these toxicants (Valchev et al., 2008; Horak et al., 2018). Because 
there is a time delay from when the target pest species consumes a lethal dose to when 
that individual finally perishes, the rodent may continue feeding and accumulating ARs, 
ultimately reaching a concentration many times greater than what is needed to cause 
mortality (Stansley et al., 2014). Even after death, SGARs are particularly persistent in 
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tissues, resulting in the accumulation of toxicants. This increases the potential for 
secondary exposure to non-target predatory wildlife (Stansley et al., 2014). Additionally, 
ARs alter rodent behavior, rendering them more susceptible to predation (Cox and Smith, 
1992). Less frequent routes of exposure include direct skin contact (Spiller et al., 2003) 
and through drinking water contaminated with the toxicants (Valchev et al. 2008; 
Gómez-Canela et al., 2014; Kotthoff et al., 2019).  
For non-target avian species that have been tested, the median lethal dose (LD50) 
varies by compound and species but has been found to range from 0.26 - 3,158 mg/kg 
after exposure (Nakayama et al., 2019). Compared to rodents and some other species of 
birds, raptors appear to be more sensitive and susceptible to ARs, which may help explain 
the higher frequency of reported AR poisonings for this group. For instance, one such 
AR, diphacinone, is 20 - 30 times more acutely toxic to American kestrels (Falco 
sparverius) than to mallards (Anas platyrhynchos; Rattner et al., 2011). Possible reasons 
behind the increased susceptibly of raptors include decreased rates of AR metabolism by 
both cytochrome P450 and vitamin K 2,3-epoxide reductase inhibition, longer 
elimination times, and the additional binding of ARs to proteins (Horak et al., 2018; 
Nakayama et al., 2020).  
Less understood are the effects of non-lethal doses of ARs to non-target wildlife 
at both a population and individual level. Some previously discovered sub-lethal effects 
include lower occupancy rates, decreased breeding performance, decreased feeding 
activity, increased sensitivity to further exposure, hemorrhage following injury, induced 
neuropathology, and immunosuppression (Mosterd and Thijssen, 1991; Eason et al., 
1999; Salim et al., 2014; Serieys et al., 2015; Kalinin et al., 2017). 
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The U.S. Environmental Protection Agency (EPA) concluded that SGARs pose a 
substantial risk to non-target wildlife and issued a risk mitigation decision for ten 
different rodenticides (US EPA, 2008). This decision halted the sale of brodifacoum, 
difenacoum and difethialone in retail outlets beginning in June 2011. Currently, SGARs 
are no longer registered for use in products geared towards residential consumers and are 
only available to licensed pest controllers (US EPA, 2008). To apply SGARs, the EPA 
has a requirement for bait to be bought in bulk at a minimum of 16 pounds (7.3 kg) by 
professional users, minimizing the general public’s access to these toxicants. In addition, 
the EPA has issued site restrictions for the application of SGARs, including using bait 
stations when applying for outdoor, above-ground use to help limit non-target wildlife 
exposure (EPA, 2017). 
Even with these restrictions, SGARs are still heavily used by pest management 
professionals. In Massachusetts, 97% (n = 35) of companies that provide rodent control 
services reported using chemical rodenticides, with the SGAR bromadiolone being most 
commonly used (57%, n = 30) in 2015 (Memmott et al., 2017). FGARs, such as 
chlorophacinone and diphacinone, are still commercially available to the general public 
in ready-to-use bait stations that are labeled for use indoors or outdoors within 50 feet 
(15.2 m) of buildings (EPA, 2017).  
Rodents are also pests in agricultural settings where they cause an estimated $50 
billion annually in crop damage, so rodenticides are commonly used to limit losses 
(Eason et al., 2010). Even though data on sales in the AR market are largely considered 
confidential, there is some indication of how prevalent and widespread ARs are used 
around agriculture. For example, there were more than 450 tons of AR product sold for 
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agricultural purposes in California in 2007 alone (Rattner et el., 2014). Two FGARs, 
Rozol® (chlorophacinone) and Kaput-D® (diphacinone), are registered in 10 states to 
control black-tailed prairie dog (Cynomys ludivicianus) populations (Vyas et al., 2017). 
In Colorado, approximately 216 kg of Rozol® was applied to 4,080 black-tailed prairie 
dog colonies in 2010 (Vyas et al., 2013). To mitigate the potential effects that these 
poisoned prairie dogs (Cynomys spp.) have on non-target predators, the EPA mandates 
that the applicators must return to the site multiple times to collect and dispose of 
carcasses (EPA, 2017). The degree to which applicators adhere to this regulation is 
unclear, and there is evidence that this rule is sometimes ignored (Vyas et al., 2013; 
Memmott et al., 2017). Currently, there is still a high dependence on ARs for rodent 
control, variation in levels of awareness of the risk that ARs pose to non-target wildlife, 
and inconsistences in AR regulation adherence (Memmott et al., 2017).  
Thus, given the widespread and heavy use of rodenticides in residential, 
agricultural, and rangeland systems, there is a huge need to monitor their potential effects 
on non-target wildlife populations. My thesis consists of two chapters focused on (1) the 
prevalence of non-target AR exposure of a predatory bird of prey, and (2) an 
investigation of a rapid assessment tool for AR exposure of free-living raptors. 
Chapter 1 summarizes field surveys I conducted in the western United States to 
characterize non-target anticoagulant rodenticide exposure of free-living raptors. My 
overarching goal was to describe the interplay among raptor behavior, rodent type and 
behavior, land cover, and anthropogenic factors in non-target exposure to ARs. I used 
free-living ferruginous hawks (Buteo regalis) breeding in Idaho, Wyoming, and Colorado 
as a case study of a species potentially at risk of secondary AR poisoning. Ferruginous 
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hawks are rodent specialists that feed primarily on ground squirrels (Urocitellus spp.) and 
prairie dogs (Cynomys spp.), both of which are common pest targets for ARs (Giovanni et 
al. 2007; Ng et al., 2017). In fact, ferruginous hawks preferentially forage at AR-treated 
black-tailed prairie dog colonies (Vyas et al., 2017), indicating that this hawk species is at 
risk for secondary exposure. I used three diagnostic metrics to assess the risk of AR 
exposure to ferruginous hawk nestlings: whole blood assays, assays of opportunistically 
collected livers from hawks and hawk prey, and clotting-time assays (prothrombin time, 
PT). 
In my second chapter, I evaluated the ability of a point-of-care (POC) device 
originally developed for human use to rapidly assess AR exposure within birds of prey. 
There is a clear need to develop methods for rapid assessment of AR exposure in birds of 
prey because of the potential impacts of ARs on non-target wildlife. Furthermore, an 
easily deployed AR assay will aid in understanding the prevalence and sub-lethal effects 
of AR exposure in raptor populations (Hindmarch et al., 2019). Human patients on oral 
anticoagulant therapy commonly take warfarin, a FGAR, and they must be closely 
monitored (Wells et al., 2007). To improve safety and decrease cost to patients, multiple 
POC devices have been developed to measure PT, a metric used to adjust drug dosage 
(Wells et al., 2007). PT is also a useful biomarker of AR exposure in birds of prey 
(Murray and Tseng, 2008; Rattner et al., 2010; Hindmarch et al., 2019). Specifically, I 
tested the precision and accuracy of PT estimates from the Coag-Sense® PT/INR 
Monitoring System manufactured by CoaguSense Inc. (Fremont, California), one such 
POC device, using avian blood samples. 
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My studies were approved by the Boise State University Animal Care and Use 
Committee (protocols #006-AC18-003 and #AC17-015), and all of the appropriate 
biosafety protocols (protocol #IBC18-006) and State and Federal permits were obtained 
to conduct this research (Colorado Parks and Wildlife scientific collection license 
#19trb2091a, state of Idaho wildlife collection /banding/ possession permits #110728 and 
#990121, Wyoming Chapter 33 permit #729, US Geological Survey Federal Bird 
Banding Permits #23715 and #22929).  
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CHAPTER ONE: ASSESSING ANTICOAGULANT RODENTICIDE EXPOSURE OF 
FERRUGINOUS HAWK NESTLINGS 
Abstract 
Through unintentional secondary poisoning, anticoagulant rodenticides (ARs) 
threaten raptors - especially species that primarily consume rodents. Although exposure 
to ARs in free-living raptor populations is documented on at least three continents, 
patterns and pathways of exposure are not well studied, so potential effects of ARs on 
raptor populations remain difficult to quantify and mitigate. I evaluated the risk of AR 
exposure of ferruginous hawks (Buteo regalis) in Idaho, Wyoming and Colorado in the 
western United States. These hawks inhabit shrub steppes, grasslands, and deserts, many 
of which are modified by agriculture, wind power, and oil and gas development. 
Rodenticides are often deployed in developed areas to reduce numbers of burrowing 
mammals. Targeted pest species include ground squirrels (Urocitellus spp.) and prairie 
dogs (Cynomys spp.), which compose a large proportion of ferruginous hawk diet. 
Despite the potential for exposure, no AR residues were detected in the 173 blood 
samples that I collected from ferruginous hawk nestlings at 60 nest sites over two 
consecutive breeding seasons (2017 – 2018). To elucidate possible exposure pathways, I 
also opportunistically collected and analyzed 54 liver samples from prey items and four 
from recently deceased, opportunistically collected ferruginous hawks. Brodifacoum was 
detected in one prey liver sample (1.9%) from a ground squirrel, but at a minute 
concentration (0.003 ppm). I also collected 117 citrated plasma samples from nestling 
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hawks and analyzed them for prothrombin time (PT) which is a biomarker for AR 
exposure. Prothrombin time averaged 29.8 ± 4.8 (SD) seconds (range: 21.3 – 41.2 sec). 
PT values were normally distributed, indicating no evidence of AR exposure. Sex was a 
strong predictor of PT, with female nestlings exhibiting longer PT than males. These 
findings aid in understanding the risk of AR exposure to ferruginous hawk nestlings in 
Idaho, Wyoming and Colorado, and contribute important baseline information on PT. 
Introduction 
Anticoagulant rodenticides (ARs) have been in use globally since the 1950’s to 
control rodent populations (Hadler and Buckle, 1992). ARs work by inactivating vitamin 
K epoxide reductase in the liver, which disrupts clotting factor synthesis and 
subsequently the clotting cascade (Rattner et al., 2014). The vitamin K-dependent clotting 
mechanism is highly conserved in vertebrates, enabling ARs to have toxic effects on non-
target species (Doolittle and Feng, 1987; van den brink et al., 2018). In fact, recent 
studies document exposure of a high percentage of non-target animals of a variety of 
predator and prey taxa, including those that prey on or scavenge rodents (Nakayama et 
al., 2019).  
Secondary exposure to ARs typically occurs through the ingestion of 
contaminated prey tissues, leading to the bioaccumulation and biomagnification of ARs 
within non-target predatory wildlife (Giraudoux et al., 2006). Adding to the risk of 
secondary exposure to predators, rodents can live 1-3 weeks after ingesting ARs (EPA, 
2017). After initial exposure to ARs, rodents experience lethargy, loss of attentiveness, 
disruption of their internal biorhythm, hemorrhaging, and altered predator responses. The 
combination of these symptoms makes them easier targets for predatory wildlife (Cox 
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and Smith, 1992; EPA, 2017). In particular, it appears that species of predators that 
specialize on rodents, or those that are opportunistic scavengers, are at the highest risk of 
secondary AR exposure (van den Brink et al., 2018). 
The prevalence of AR residues in birds of prey is most frequently documented in 
the course of a post-mortem evaluation. ARs accumulate and persist within the liver, 
often resulting in detectable and high concentrations (Vadenbroucke et al., 2008). 
However, less is known about the ante-mortem effects of AR exposure experienced by 
individuals in free-living populations. Liver assays are limited in their ability to provide 
information on potentially subtle sub-lethal effects, or on the timing and frequency of AR 
exposure events, and they are not applicable for free-living animals (Hindmarch et al., 
2019). In contrast, more readily available tissues, such as blood, can be assayed for AR 
residues, although this method typically only provides information about recent exposure 
(Martínez-Padilla et al., 2017; Abernathy et al., 2018). 
In addition to direct assays for AR compounds in blood plasma, clotting time 
assays, such as PT, can be effective biomarkers for AR exposure in live animals (Murray 
and Tseng, 2008; Rattner et al., 2010; Hindmarch et al., 2019). PT measures the 
functional activity of the common coagulation pathway by calculating the time in seconds 
that it takes for a fibrin clot to form (Morrisey et al., 2003; Campbell, 2015). PT is 
measured by adding tissue thromboplastin and calcium to the plasma to activate the 
clotting cascade, which converts prothrombin to thrombin and subsequently converts 
fibrinogen to a fibrin clot (Fig 1.1; Morrisey et al., 2003; Rattner et al., 2010). ARs 
inhibit the vitamin K-dependent synthesis of a series of clotting factors (II [prothrombin], 
VII, IX and X), resulting in an increased PT (Rattner et al., 2010). PTs greater than 125% 
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of normal estimates are usually considered to be indicative of AR exposure (Shlosberg 
and Booth, 2006). 
Baseline estimates of PT are not well established for many species (Hindmarch et 
al., 2019). For those species in which PT has been measured, the estimates can vary 
widely by study, population and laboratory (Table 1.1). For example, two recent studies 
estimated mean PT for barn owls (Tyto alba) as 8.7 sec and 22.6 sec (Webster et al., 
2015; Hindmarch et al., 2019). PT estimates in mammals can vary because of inherent 
laboratory variation, but also because of vitamin K supply, animal age and sex, time of 
blood collection, and elevation (Bertolucci et al., 2005; Patot et al., 2006; Lemini et al., 
2007; Sakata et al., 2007). However, such influences are less well known for avian 
populations.  
In North America and Europe, Buteo hawks appear to have a relatively high risk 
of AR exposure (López-Perea and Mateo, 2018). For instance, AR prevalence in red-
tailed hawks (Buteo jamaicensis), rough-legged buzzards (Buteo lagopus), and common 
buzzards (Buteo buteo) was 76%, 84%, and 94%, respectively (Stone et al., 1999; Stone 
et al., 2003; Murray, 2011; Christensen et al., 2012). Ferruginous hawks (B. regalis) in 
North America are potentially at similar risk for AR exposure but have not been well 
studied. Ferruginous hawks inhabit open landscapes including shrub steppes, grasslands, 
canyonlands, and deserts (Bechard and Schmutz, 1995). These open landscapes are 
important for natural gas development, wind power generation, rangelands, and crop 
production, and in each case rodent populations are often managed through the 
application of ARs. Higher levels of AR exposure occur in non-target species that inhabit 
rangelands, specifically in areas with a high density of cattle (Shore et al., 2006; Geduhn 
18 
 
 
 
et al., 2015; López-Perea et al., 2019). Adding to the risk of encountering ARs, 
ferruginous hawks feed primarily on ground squirrels (Urocitellus spp.) and prairie dogs 
(Cynomys spp.), both of which are common targets of ARs (Bechard and Schmutz, 1995; 
Vyas et al., 2017). Moreover, ferruginous hawks preferentially forage at black-tailed 
prairie dog (Cynomys ludovicianus) colonies treated with ARs, which increases the 
likelihood of secondary exposure (Vyas et al., 2017). 
The objectives of my research were as follows: 1) to assess AR exposure of 
ferruginous hawks in relation to land cover type and distance to anthropogenic 
influences, and 2) to elucidate possible exposure pathways by assessing ARs in hawk 
prey species. To address my first objective, I sampled and assayed whole blood samples 
for AR residues from ferruginous hawk nestlings across a large geographic area that 
included three states in the western United States. I also collected citrated plasma samples 
and assessed clotting time as a biomarker for AR exposure and examined how this metric 
varied in nestlings in free-living populations. Lastly, I obtained and assayed livers from a 
small number of dead ferruginous hawks that were opportunistically collected in 
collaboration with other researchers and wildlife rehabilitators in my study areas to 
understand if a discrepancy is present when assaying different tissue types (livers vs. 
blood). To address my second research objective, I collected livers from common species 
of ferruginous hawk prey within my study areas and assayed them for AR residues to 
identify prey bases that may increase the risk of secondary exposure to ferruginous 
hawks.  
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Methods 
Although I also collected samples from adult ferruginous hawks and their prey, I 
primarily focused my survey of AR exposure on nestlings for a number of reasons. First, 
exposure to contaminants during the reproduction and nestling stage can be the most 
consequential (Herring et al., 2017). For instance, exposure to ARs during the nestling 
stage could lead to decreased bone density and poor healing, ultimately manifesting in 
low body condition (Knopper et al., 2007). Secondly, nestlings have large energy needs 
during growth, which can result in a high level of rodent consumption (Keeley and 
Bechard, 2017). This increases the probability that nestlings could encounter 
contaminated prey. Next, nestlings are only in the nest for a short period of time, 
generally 38-50 days (Howard, 1975; Ng et al., 2017). The plasma half-life (t1/2) of ARs 
is substantially shorter than in liver tissue, resulting in a short window of detection 
(Martínez-Padilla et al., 2017; Abernathy et al., 2018). The plasma t1/2 depends on 
individual compound and species, but for mice it ranges from 20.4 – 91.7 d (Nakayama et 
al., 2019). The amount of time that the nestlings are in the nest is likely to overlap with 
the plasma t1/2 of many AR compounds, providing an accurate reflection of AR exposure 
during this life-stage and reducing the chance of false negatives. Finally, nestlings are 
logistically easier to capture than adults. 
Study Area 
I monitored ferruginous hawk nestlings in southwestern Idaho, southern and 
central Wyoming, and in a small portion of northeastern Colorado (Fig. 1.2) between 
May and July in both 2018 and 2019. I sampled hawks from nests on artificial nest 
platforms, in trees, on the ground, and on other human structures. The nests were located 
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on both public and private lands in a variety of landcover types, and they varied in their 
distances to agriculture, energy development, rangelands, and anthropogenic 
infrastructure. Hawks nesting in Wyoming and Colorado had access to prairie dogs 
(Cynomys spp.) as a primary prey species, whereas in Idaho where prairie dogs do not 
inhabit, hawks fed primarily on ground squirrels (Urocitellus spp.). 
Whole Blood Sample Collection and AR Analysis 
In both 2018 and 2019, I hand captured ferruginous hawk nestlings after 
accessing nests with ladders or climbing gear, temporarily removed them from the nest, 
and restrained them in canisters for blood collection and measurements. I banded each 
nestling with a U.S. Geological Survey metal leg band and assigned age and sex (when 
possible) based on morphology (Moritsch, 1985; Gossett, 1993). To ensure that samples 
were <1% of body mass, only nestlings >0.2 kg were sampled. I used a 25-ga butterfly 
needle to collect 2 ml of whole blood from the brachial vein, transferred the blood into a 
3-ml tube with EDTA (k3), inverted the tube several times for mixing, and kept the blood 
on ice in a cooler in the field until transfer into a refrigerator for longer term storage at 
4°C.  
When nestlings were too small for 2 ml to be collected, such as earlier in the 
breeding season when they were younger, I collected 0.5 ml from each nestling in a 
single nest and pooled the blood to gain an understanding of the nest-level exposure to 
ARs. The nestlings that contributed to these pooled samples were later resampled in the 
same year when they were older and larger, and 2 ml of blood was collected at this time. I 
also opportunistically collected whole blood from adult ferruginous hawks that other 
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researchers in my study areas captured using a modified dho ghaza with a mechanical 
owl lure (Bloom et al., 2007; Jensen et al., 2019).  
All whole blood samples were analyzed for the presence of bromadiolone, 
brodifacoum, difethialone, difenacoum, chlorophacinone, diphacinone, coumatetralyl, 
pival and warfarin. Analysis was by high-performance liquid chromatography (HPLC) 
with fluorescence UV detection and mass spectrometry and/or liquid chromatography 
with tandem mass spectrometry (LC/MS/MS) and was conducted at the Louisiana 
Animal Disease Diagnostic Laboratory and the Texas A&M Veterinary Medical 
Diagnostic Laboratory, which are both fully accredited by the American Association of 
Veterinary Laboratory Diagnostics. 
Prothrombin Time, Thrombin Clotting Time, and Fibrinogen Concentration 
In 2019, I also collected citrated plasma samples as described by Hindmarch et al. 
(2019) for analysis of PT, thrombin clotting time (TCT), and fibrinogen concentration. 
TCT measures the time it takes for fibrinogen to be converted into fibrin after thrombin is 
added to the plasma. TCT is then used to calculate fibrinogen concentration (Fig. 1.1; 
Rattner et al., 2010). Fibrinogen concentration is insensitive to vitamin K clotting factor 
deficiencies, meaning that it is not affected by AR exposure. As such, it is a measure of 
sample quality because its concentration in blood can be reduced by improper sample 
collection and handling (Rattner et al., 2010; Hindmarch et al., 2019). Lower fibrinogen 
concentration also can prolong prothrombin time separate from an AR exposure event 
and therefore help differentiate a false positive (Hindmarch et al., 2019). Typically, any 
sample that has a fibrinogen concentration >50 mg/dL is able to support clot formation 
(Hindmarch et al., 2019).  
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To collect blood for these assays, I used a 1-ml syringe previously loaded with 0.1 
ml of 3.2% sodium citrate to draw 0.9 ml of whole blood from the brachial vein in the 
wing. Immediately after collection, the blood was transferred into a 1.5 ml 
microcentrifuge tube, gently inverted several times and kept on ice until all of the 
nestlings in a nest had been processed. Samples were then centrifuged in the field at 
2,000 x g for 10 min. The resultant plasma (usually 400-600 µl) was immediately 
transferred into 1.2 ml cryovials and promptly stored frozen inside a cryoshipper 
containing liquid nitrogen vapors. Cryovials were kept in the cryoshipper until transfer 
into a -80°C freezer. Blood samples collected for PT analysis using sodium citrate were 
collected before whole blood samples for AR analysis were drawn. The citrated plasma 
was shipped on dry ice to the Comparative Coagulation Laboratory in the Animal Health 
Diagnostic Center at Cornell University (Ithaca, NY) for analysis of PT, TCT and 
fibrinogen concentration following the previously described protocol by Rattner et al. 
(2010, Appendix 1). 
Prey Liver and Ferruginous Hawk Tissue Collection and Analysis  
I opportunistically collected liver samples from rodents at 29 sites throughout my 
study areas (Fig. 1.2). Samples were obtained in two ways: 1) through access to 2 g of 
liver tissue from Piute ground squirrels collected during another ongoing research project, 
and 2) by collecting livers from all types of prey items found in ferruginous hawk nests at 
the time of blood sampling (the remainder of the carcasses was replaced in hawk nests). 
Livers that I dissected from prey items found in hawk nests were immediately frozen and 
stored inside a cryoshipper containing liquid nitrogen vapors in the field and kept there 
until transferred into a -80°C freezer. I also collected livers from three ferruginous hawks 
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found dead in the field and a fourth that was euthanized by a local wildlife rehabilitator in 
Idaho (21 March – 24 May 2019). All hawk and prey liver samples were shipped on dry 
ice to either the Texas A&M Veterinary Medical Diagnostic Laboratory (College Station, 
TX) or the Veterinary Diagnostic Laboratory at Michigan State University (Lansing, MI) 
where they were assayed for ARs as above. 
Spatial Analysis 
Ferruginous hawks have home ranges that average approximately 7.0 km2 in size, 
ranging from 3.4 – 21.7 km2 (Olendorff, 1993). Therefore, using Arc GIS (ESRI, 2015; 
ArcMap 10.4.1), I defined a 2-km radius circular buffer (12.6 km2 area) around each 
ferruginous hawk nest site reflecting a large percentage of the presumptive foraging areas 
and possible overall home range of adults tending the nest. I then used LANDFIRE 
(2014) to estimate the existing vegetation types within buffers around each nest site in 
seven categories: water, tree, sparse, herbaceous, developed, shrub, and agriculture 
(Table A2.1). I divided the number of cells of each cover type by the total number of 
cells in the 2-km buffer and multiplied by 100 to obtain percent cover by type. Ground 
elevation (m) was calculated for each nest site using a Digital Elevation Model (DEM; 
U.S. Geological Survey, 2017). 
Statistical Analyses 
All statistical analyses were performed using R software version 3.5.1 (R Core 
Team, 2018). Because ARs were not detected in birds, I was unable to model the risk of 
AR exposure as a function of landcover correlates and prey base. Normality of the 
clotting time data was assessed using the Shapiro-Wilk test. To model the variation of PT 
as a function of ecological factors, I created competing linear-mixed effects models using 
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the package “lme4” (Bates et al., 2015). In these models, mass, sex, age, percent shrub 
cover, percent herbaceous cover, elevation, and time of blood collection were predictor 
variables with PT as the response variable. I used nest site as a random effect to account 
for the dependency among observations as multiple nestlings were frequently sampled at 
each nest (Fig. A2.1). Multicollinearity among predictor variables was assessed by 
computing variance inflation factors (VIF) using the package “car” (Fox and Weisberg, 
2019). Variables that had a variance inflation factor greater than five were removed from 
the final model set. Final fixed covariates (Table 1.2) included sex, age in days, the 
elevation of the nest site, the time of day when each blood sample was collected, and 
percent shrub cover around the nest site. Nestlings in which a putative sex could not be 
assigned were removed from analysis. Because the continuous predictor variables were at 
different scales of measurement, I standardized them prior to analysis using the ‘scale’ 
function in base R, which subtracts the mean and divides by the standard deviation of the 
data set.  
I created a global model that included all five final fixed effects and a random 
effect for nest site. Next I employed the model selection function “dredge” in the package 
“MuMln” (Bartoń, 2019) which generated 32 models with every combination of the five 
fixed effect terms from the global model (Table 1.3 and Fig. 1.3). I compared the models 
using Akaike’s information criterion (AIC; Akaike, 1973; Burnham and Anderson, 
2002). No model had a majority of weights, indicating high model selection uncertainty 
(Symonds and Moussalli, 2010). To accommodate for this uncertainty, I then used a full 
model averaging approach, using the function “model.avg” in the package “MuMIn” 
(Bartoń, 2019) to estimate PT parameters. Model assumptions were validated by plotting 
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the residuals against fitted values. Means are given with standard deviations except where 
indicated.  
Results 
Whole Blood Sample Collection and AR Analysis 
I collected and assayed whole blood samples (Table A2.2) from 60 ferruginous 
hawk nests in 2018 and 2019 (Table 1.4). Nests were located on artificial structures (n = 
52) and on natural substrates (n = 8). At the time of blood collection, estimated age of 
nestlings was 31 ± 6.3 d (range: 19 – 45 d, n = 171), and they weighed 1.17 ± 0.25 kg 
(range: 0.71 – 1.72 kg, n = 171). Bromadiolone, brodifacoum, difethialone, difenacoum, 
chlorophacinone, diphacinone, coumatetralyl, pival and warfarin were not detected in any 
of the whole blood samples. The limit of detection (LOD) for assays ranged from 0.008 – 
0.083 ppm. 
Prothrombin Time, Thrombin Clotting Time, and Fibrinogen Concentration 
I collected citrated plasma samples from 127 ferruginous hawk nestlings in 2019 
from Idaho (n = 57), Wyoming (n = 66) and Colorado (n = 4). I subsequently excluded 10 
samples from analysis because they were either hemolyzed or had clot fragments present 
(Table A2.3). The remaining 117 samples came from 44 nest sites (n = 18, 23, and 3 from 
ID, WY and CO, respectively). At time of blood collection, these nestlings were 32 ± 6.4 
d old (range: 17 – 42 d), weighed 1.2 ± 0.26 kg (range: 0.8 – 1.7 kg), and included 52 
putative females, 40 putative males, and 25 individuals for which sex could not be 
assigned. A subset of 101 samples had sufficient remaining plasma for calculation of 
fibrinogen concentration. Prothrombin times were normally distributed (Shapiro-Wilk: w 
= 0.97, p = 0.06), and the coefficient of variation (CV) for PT was 16%. PT was 29.8 ± 
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4.8 sec (range: 21.3 – 41.2 sec), TCT was 7.1 ± 1.5 sec (range: 1.0 – 17.6 sec) and 
fibrinogen concentration was 117.0 ± 21.8 mg/dL (range: 67.0 – 178.0 mg/dL). 
The model results suggested that PT was higher in females than in males and that 
sex class was the best predictor for PT (Table 1.5). This model predicted an average PT 
of 31.66 sec (95% CI 30.33 – 33.00) for female nestlings versus 28.39 sec for males 
(95% CI = 25.48 – 31.31). There was no association between PT and any of the other 
predictor variables as their confidence intervals for parameters overlapped zero (Table 
1.5).  
Prey Liver and Ferruginous Hawk Tissue Collection and Analysis  
I analyzed 54 prey livers collected from a total of 29 sites (n = 18, n = 10, n = 1 
from ID, WY and CO, respectively; Table 1.6), 13 of which were hawk nests. No ARs 
were detected prey livers collected directly from ferruginous hawk nests or in the 
majority of livers collected outside of hawk nests. However, brodifacoum was detected in 
one sample (1.9%) from a Piute ground squirrel collected in Idaho, but at very low 
concentration (0.003 ppm, LOD = 0.002 ppm). There were no AR residues detected in 
the four ferruginous hawk livers analyzed (LOD varied by compound; range: 0.005 – 
0.020 ppm). 
Discussion 
Though I was able to survey a broad geographic area and evaluate a number of 
different markers for exposure, I detected no evidence of AR exposure in ferruginous 
hawk nestlings in my study areas. Only one liver sample from a prey species contained 
ARs, and this was at a minute concentration. No ARs were detected in prey collected 
directly from hawk nests and all other livers from potential species tested. In evaluating 
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PT of ferruginous hawks, the low CV (16%) and normally distributed data also support 
the conclusion that AR exposure was absent. Despite no apparent AR exposure in 
nestlings during the breeding season, my study provided important baseline information 
about PT in ferruginous hawks and factors associated with PT variability.  
Sex was a strong predictor of PT of nestling hawks, such that females had longer 
clotting times than males. This trend was not seen in the PT measurements of raptors 
admitted to a rehabilitation center (Hindmarch et al., 2019), but it parallels patterns in 
humans and rodents (Lemini et al., 2007; Sakata et al., 2007). This raises the question of 
whether wild female raptors may disproportionately be affected by AR exposure. That is, 
if the baseline PT is higher for females as compared to males, then an encounter with an 
AR that increases PT may push the PT of females into a lethal range with a smaller dose. 
To the best of my knowledge, this concept has not been explored through research but 
could result in sex-biased mortality from AR exposure. 
My study provided a snapshot of exposure profiles within a specific age structure 
and season for ferruginous hawks. The substantial differences between my findings, 
where there was little indication of AR exposure, and those from previous research, 
where AR exposure in the Buteo genus ranges from 44% to 95% (López-Perea and 
Mateo, 2018), highlights how much remains unknown about AR prevalence, use and 
effects. For instance, despite an indication of low exposure during the nestling phase, it is 
possible that AR use varies seasonally, putting ferruginous hawks at risk of encountering 
these toxicants along their migration route or in their wintering grounds. In fact, Rozol®, 
a FGAR, is registered in 10 states in the U.S. to control black-tailed prairie dogs from 1 
October to 15 March (Vyas et al., 2017). In Europe, the number of AR-poisoned 
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predators increases in late fall and early spring in conjunction with seasonal application 
of ARs (Berny et al., 1997; Berny and Gaillet, 2008). In Northern Ireland, most 
applications occur in the fall and winter (Tosh et al., 2011). This highlights the 
importance of additional studies to continue to assess the risk of ARs to ferruginous 
hawks including outside of the breeding season.   
Prothrombin Time as a Biomarker for AR Exposure 
The PT estimates recorded in ferruginous hawk nestlings in my study were longer 
than most reported for other avian species (Table 1.1; Fig. 1.4). There was adequate 
fibrinogen concentration present in the samples, indicating that sample quality was good, 
so the longer PT values I observed were not caused by improper collection or handling. 
Outside of sample quality, there are several possible explanations for this observed 
pattern.  
First, variability in PT among species is likely explained in part by inherent 
differences in coagulation enzymes. For instance, PT in chickens (Gallus gallus 
domesticus) is shorter, ranging from 8.4-13.9 seconds (Stopforth, 1970; Doerr et al., 
1975; Morrisey et al., 2003) than brown kiwis (Apteryx australis mantelli), which 
averaged 24.3 sec (Morrisey et al., 2003). Ostriches (Struthio camelus) have even longer 
PT, averaging 73.0 sec, which is suspected to be the result of reduced levels of clotting 
factors II, V, and VIII in the plasma as compared to other species (Frost et al. 1999). 
Therefore, the longer PT estimates in ferruginous hawk nestlings compared to previously 
reported PT values in raptors (Fig. 1.4) could be related to inter-species differences. 
However, significant intra-species variation could also reflect differences in laboratory 
methodology and thromboplastin reagents, which could obscure inter-species differences. 
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For example, the PT of ostriches varies substantially when the type of thromboplastin 
used for the assay was changed. When a chicken-based reagent is employed for ostriches, 
the mean PT is 90.1 sec in contrast to using a homologous-based reagent, which results in 
a mean PT of 73.0 sec (Frost et al., 1999). Moreover, when analyzed separately, two 
studies reported that the mean PT of barn owls differed by about 10 seconds (Webster et 
al., 2015; Hindmarch et al., 2019). To better understand inter-species variation in 
coagulation, further standardization of clotting time assays across laboratories is likely 
needed.  
The age of individuals may also contribute to variability in reported PT. Most 
previous studies have analyzed PT of adult birds, whereas my study focused on nestlings. 
This difference in life stage (nestlings vs. adults) may partially explain the higher values 
that I observed in ferruginous hawks compared to other raptor species. This possibility is 
supported by studies showing that the coagulation system of healthy human infants 
differs from that of adults, with the number of vitamin K-dependent factors ranging 
between 25% to 70% of adult values, contributing to prolonged prothrombin times in 
infants (Andrew et al., 1988). Whether a similar phenomenon occurs in avian species is 
unknown because of a general dearth of studies.  
Next, exposure to ARs can increase prothrombin time (Rattner et al., 2010), 
although it does not appear to be the underlying factor for the lengthy prothrombin times 
observed in ferruginous hawk nestlings. Large disparities in PT within a population can 
indicate AR exposure, which is usually reflected in a higher CV (Webster et al., 2015). 
For instance, in a controlled AR dosing experiment using Japanese quail (Coturnix 
japonica), the CV of PT for each experiment ranged from 25-115% depending on the 
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dose, versus a CV of 10.5% in control quail that did not receive ARs (Webster et al., 
2015). The CV of PT in a free-ranging, unexposed barn owl population was 14% 
(Webster et al., 2015). The CV of PT that I found (16%) in ferruginous hawk nestlings is 
similar in magnitude to the previously mentioned control group of quail and in the 
unexposed population of owls, which I interpret as arising from inter-individual 
differences and not AR exposure events. 
Another method for assessing if AR exposure has occurred in individuals is based 
on identifying PT values are greater than 125% of baseline values (Shlosberg and Booth, 
2006). However, baseline PT values are not well established for raptor species, including 
ferruginous hawks, which are rarely kept in captivity. To account for this missing 
information, Hindmarch et al. (2019) used a more conservative metric (150% of baseline 
values) to make conclusions about AR exposure in birds of prey. If the median PT (29.1 
sec) of the ferruginous hawk nestlings that I measured is assumed to represent a baseline 
for this species and age structure, then none of the PT values from the current study 
exceed 150% of that baseline value (43.7 sec), indicating no AR exposure (Fig. 1.4). 
Rather than using species-specific thresholds for determining AR exposure, Hindmarch 
et. al (2019) used the median PT estimate (12.4 sec) established from captive American 
kestrels (Falco sparverius) to assess AR poisoning in a number of raptor species admitted 
to a wildlife rehabilitation center (Fig. 1.4). If I were to apply a similar threshold, then 
nestlings with a PT >31.0 seconds would be assumed to have been exposed to ARs, and 
40 (34%) ferruginous hawk nestlings in my study would meet this criterion. However, the 
lack of AR residues detected in any liver sample and the small CV of PT in hawk 
nestlings both suggest no exposure. Thus, simply using a PT baseline value for American 
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kestrels likely is not appropriate for ferruginous hawks. This highlights the importance of 
further research evaluating clotting time in various species and the benefits of using a 
combination of diagnostic methods to examine AR exposure in free-living populations.  
Conclusions 
My study is among the first to evaluate the risk of AR exposure of free-living 
ferruginous hawk nestlings during the breeding season in the western United States. 
Based on the results from the multiple approaches that I used (e.g., assaying blood for AR 
residues, examining liver, and measuring aspects of clotting time), it appears that 
ferruginous hawk nestlings were not encountering ARs. However, AR use on the 
landscape, and therefore AR exposure in ferruginous hawks, could vary temporally, so 
surveillance is still necessary, especially because of ongoing population declines in this 
species and its heightened conservation status. My findings also allow managers and 
researchers to refocus some of their resources on evaluating the risk of AR exposure of 
ferruginous hawks outside of the breeding season. In addition, the longer prothrombin 
times I recorded in ferruginous hawk nestlings, a species where information on clotting 
time parameters was lacking, indicates substantial inter-species variation when compared 
to previously studied species of raptors.  
Assessing the risk of AR exposure of live birds of prey presents challenges, 
especially given the short half-lives of AR compounds in the blood of animals. Thus, 
false negatives are possible when assessing AR exposure in wild birds based solely on 
blood samples. As such, using a combination of diagnostic metrics may be needed to 
fully assess exposure in free-living populations. In addition to direct assays, approaches 
can include measuring clotting parameters, like PT, and assaying other biological 
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materials, such as feces, pellets and eggs (Eadsforth et al., 1991; Giorgi and Mengozzi, 
2010; Sage et al., 2010). Honing methodology to assess AR exposure in free-living 
populations will provide a better understanding of exposure rates to non-target wildlife 
and potential sub-lethal effects of the toxicants.
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Table 1.3 Competing models for exploring prothrombin time (PT) as a function 
of Age, Elevation, Sex, Shrub Cover, and Time of Day in ferruginous 
hawk nestlings in Idaho, Wyoming and Colorado in 2019. All models 
included an intercept and random effect for nest site. The number of 
parameters (K), log-likelihood (LL), Akaike’s Information Criterion 
corrected for small sample sizes (AICc), 𝚫AICc, and Akaike weight 
(wi) are provided for each model. Models were later averaged. 
Model Structure K LL AICc 𝚫AICc wi 
Age + Elevation + Sex 6 -255.01 523.01 0.00 0.24 
Age + Elevation + Sex + Shrub Cover 7 -254.51 524.35 1.34 0.12 
Age + Sex + Shrub Cover 6 -255.70 524.39 1.38 0.12 
Elevation + Sex 5 -256.99 524.67 1.66 0.10 
Age + Elevation + Sex + Time 7 -254.84 525.02 2.01 0.09 
Sex + Shrub 5 -257.41 525.51 2.50 0.07 
Elevation + Sex + Time 6 -256.67 526.34 3.33 0.05 
Elevation + Sex + Shrub Cover 6 -256.78 526.54 3.53 0.04 
Age + Sex + Time + Shrub Cover 8 -254.47 526.67 3.66 0.04 
Age + Elevation + Sex + Time + Shrub 
Cover (Global) 
7 -255.70 526.73 3.72 0.04 
Sex +Time + Shrub Cover 6 -257.30 527.59 4.58 0.02 
Sex 4 -259.60 527.65 4.65 0.02 
Elevation + Sex + Time + Shrub Cover 7 -256.58 528.48 5.48 0.02 
Sex + Time 5 -259.10 528.90 5.89 0.01 
Age + Sex 5 -259.23 529.16 6.15 0.01 
Age + Sex + Time 6 -258.80 530.58 7.57 0.01 
Age + Elevation 5 -262.73 536.15 13.14 0.00 
Age + Elevation + Shrub Cover 6 -262.35 537.68 14.67 0.00 
Age + Shrub 5 -263.78 538.25 15.24 0.00 
Elevation 4 -264.95 538.37 15.36 0.00 
Age + Elevation + Time 6 -262.70 538.40 15.39 0.00 
Shrub Cover 4 -265.61 539.68 16.67 0.00 
Age + Elevation + Time + Shrub Cover 7 -262.34 540.02 17.01 0.00 
Elevation + Shrub Cover 5 -264.83 540.35 17.35 0.00 
Elevation + Time 5 -264.86 540.41 17.40 0.00 
Age + Time + Shrub 6 -263.74 540.47 17.46 0.00 
Intercept Only (Null)  3 -267.61 541.49 18.48 0.00 
Time + Shrub 5 -265.60 541.91 18.90 0.00 
Elevation + Time + Shrub Cover 6 -264.78 542.55 19.54 0.00 
Age 4 -267.14 542.74 19.73 0.00 
Time 4 -267.40 543.26 20.25 0.00 
Age + Time 5 -266.98 544.65 21.64 0.00 
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Table 1.4 Number of whole blood samples collected and analyzed for AR 
residues from ferruginous hawk nests in 2018 – 2019 in three western 
states in the USA. The parentheses around nest sites indicate the 
number of nests that were sampled in both 2018 and 2019. Pooled 
samples contained blood collected from >1 nestling in a single nest to 
reach the 2-ml minimum required for the AR assay. 
State Nest Sites Nestlings Adults Pooled1 
Idaho 22 (2) 75 2 11 
Wyoming 37 (3) 95 - - 
Colorado 1 1 - - 
Total  60 171 2 11 
 
1A total of 36 nestlings contributed to the pooled samples. On average, 3 ± 1.2 nestlings 
from each nest site were part of a pooled sample, and they were 14.3 ± 3.6 d old (range: 
7– 20 d) when sampled.  
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Table 1.5 Model averaged regression parameters, SE, and 95% CI for PT in 
nestling ferruginous hawks in Colorado, Wyoming and Idaho, USA, 
2019, derived using a linear-mixed model approach with nest site as a 
random effect. 
 
 
 
 
 
  
Covariate Parameter Estimate SE 95% Confidence Interval 
Intercept 31.66  0.67 30.33 – 33.00 
Age 0.80  0.75 -0.68 – 2.78 
Elevation -1.11  0.97 -3.01 – 0.79 
Sex -3.27  0.79 -4.85 – -1.69 
Shrub Cover -0.55  0.83 -2.19 – 1.09 
Time -0.08  0.33 -0.74 – 0.58 
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Table 1.6 Number of livers collected in 2018 and 2019, by species and state, that 
were screened for AR residues.  
1Brodifacoum was detected at a low concentration (0.003 ppm, LOD = 0.002 ppm) in one 
Piute ground squirrel liver collected in Idaho on 4 April 2018. No AR residues were 
detected in the remaining samples that were tested.   
Common Name Species Idaho Wyoming Colorado 
Northern pocket gopher Thomomys talpoides - 2 - 
Piute ground squirrel Urocitellus mollis 361 - - 
Thirteen-lined ground squirrel 
Ictidomys 
tridecemlineatus 
- 2 - 
White-tailed prairie dog Cynomys leucurus  - 10 - 
Rodent, unidentified  - 3 - 
Western meadowlark Sturnella neglecta - - 1 
Ferruginous hawk Buteo regalis 4 - - 
     
Total:   40 17 1 
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Figures 
 
Figure 1.1 Simplified schematic of the coagulation pathway in birds 
(adapted from Rattner et al. 2010). The specific components of the pathway 
measured with prothrombin time, thrombin clotting time and fibrinogen 
concentration are indicated in the blue boxes.  
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Figure 1.2 Locations of (A) ferruginous hawk anticoagulant rodenticide 
(AR) blood collection sites in 2018 – 2019 (open triangle), prothrombin time (PT) 
collection sites in 2019 (open circle), and sites where PT and AR samples where both 
collected (closed circle), and (B) prey liver (closed square) and ferruginous hawk 
liver (open square) collection sites in 2018 and 2019 in Colorado, Idaho and 
Wyoming, USA.  
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Figure 1.3 Prothrombin time (PT) of nestling ferruginous hawks in Idaho, 
Wyoming and Colorado, USA, 2019 as a function of (A) blood collection time (in 
minutes after midnight), (B) elevation, (C) shrub cover, (D) nestling age, and (E) 
nestling sex. Continuous variables are depicted with 95% confidence intervals 
(shaded gray). Categorical covariate relationships are depicted with a box plot 
where the horizontal line is the median, the box represents the interquartile range, 
and the whiskers represent the minimum and maximum.  
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Figure 1.4 Comparison of prothrombin times collected from ferruginous 
hawk nestlings in this study to bald eagles (Haliaeetus leucocephalus), Cooper’s 
hawks (Accipiter cooperi), and red-tailed hawks (Buteo jamaicensis) admitted to a 
rehabilitation clinic (from Hindmarch et al. 2019). Values are compared to the 
upper reference limit (17.3 sec), the 90% confidence interval, and 1.5 X upper 
reference limit (24.7 sec) from captive adult American kestrels (Falco sparverius) 
and the 1.5 X reference limit (43.7 sec) from ferruginous hawk nestlings. 
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APPENDIX 1 
Prothrombin Time, Thrombin Clotting Time, and Fibrinogen Concentration Assays 
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The following protocol was conducted by the Comparative Coagulation 
Laboratory in the Animal Health Diagnostic Center at Cornell University (Ithaca, NY). 
PT assays required prior preparation of avian thromboplastin. Chicken brain tissue was 
obtained from a pathology service (Cornell University) from sentinel birds submitted for 
necropsy for health surveillance purposes. Avian brain thromboplastin was prepared from 
the harvested brain tissue following a previously described protocol (Rattner et al., 2010). 
In brief, brain tissues were homogenized in 10 volumes of cold acetone, the homogenate 
centrifuged at 1,500 x g for 10 min, and the supernatant discarded. The pellet was re-
suspended in 5 ml of acetone, homogenized, centrifuged, acetone decanted, and this 
procedure was repeated. The pellet was then again re-suspended in acetone and vacuum 
filtered using a Buchner funnel with a glass microfiber filter. The material retained on the 
filter was dried overnight in a vacuum desiccator, removed from the microfiber filter, 
ground with a mortar and pestle, transferred into cryotubes in 40 mg aliquots, and then 
stored frozen at –80°C until use in PT assays.  
The clotting time tests (PT, thrombin time) were performed using a semi-
automated coagulation instrument (Start 4, Diagnostica Stago, Parsippany, NJ) with 
mechanical endpoint detection. The test samples were thawed at 37°C for 10 min and 
then held on wet ice until diluted in an equal volume of imidazole buffered saline (pH 
7.4) just before assay. The plasma dilutions were assayed in duplicate, and mean clotting 
times were used in calculations. To assay PT, frozen aliquots (40 mg) of avian 
thromboplastin were allowed to equilibrate at room temperature for 15 min before the 
addition of 2.0 ml of 25 mM CaCl2, followed by incubation at 42°C and pulse vortexing 
for 15 min. The suspension was then centrifuged at 1,000 x g for 20 min and the 
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recovered supernatant combined with equal volume 25 mM CaCl2. The PT assays were 
performed by incubating 100 µl dilute plasma at 37°C for 60 sec. Coagulation was then 
initiated by the addition of 200 µl of a warm (37°C) calcium and thromboplastin solution. 
The thrombin time was determined by incubating 100 µl of dilute plasma at 37°C for 60 
sec, and then adding 100 µl of room temperature bovine thrombin reagent (50 U/mL 
thrombin, Triniclot fibrinogen, Trinclot, Wicklow, Ireland). Fibrinogen was measured in 
an automated coagulation instrument (STACompact, Diagnostica Stago) via the Clauss 
method using the manufacturer’s human thrombin reagent and a human fibrinogen 
standard (Fibrinogen, Diagnostica Stago). Both PT and TCT assays were done in 
duplicate. The samples for fibrinogen were assayed as a single replicate to minimize the 
amount of plasma used. 
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Table A2.2 Information about the individual ferruginous hawks (n = 171 
nestlings, n = 2 adults) from which whole blood samples were 
collected and analyzed for AR residues from 2018 – 2019 in Idaho 
(ID), Wyoming (WY) and Colorado (CO), USA. No AR residues 
were detected in any of the blood samples.  
Individual ID Nest ID Date  State Sex1 
Life 
Stage 
Age 
(d)  
Mass 
(g) 
Big Baja 181 Big Baja 181 5/15/18 ID F Adult - 1863 
1207-81372 Slater's Flat 5/25/18 ID F Nestling 34 1427 
1207-81373 Slater's Flat 5/25/18 ID F Nestling 33 1389 
1207-81374 Cow Pasture  5/25/18 ID F Nestling 30 1292 
1207-81375 Cow Pasture  5/25/18 ID F Nestling 30 1269 
1207-81376 Cow Pasture  5/25/18 ID F Nestling 30 1241 
1207-81377 Surprise 5/25/18 ID F Nestling 35 1370 
1207-81378 Surprise 5/25/18 ID F Nestling 38 1479 
1957-31839 Slater's Flat 5/25/18 ID M Nestling 34 1031 
1957-31840 Slater's Flat 5/25/18 ID M Nestling 34 1002 
1957-31841 Cow Pasture  5/25/18 ID M Nestling 30 917 
1957-31842 Cow Pasture  5/25/18 ID M Nestling 30 794 
1957-31843 Surprise 5/25/18 ID M Nestling 38 1068 
1957-31844 Surprise 5/25/18 ID M Nestling 38 980 
1207-82006 Dead Pigeon B 5/29/18 ID M Nestling 30 1001 
1957-41016  Dead Pigeon B 5/29/18 ID M Nestling 32 1038 
1957-41017 Dead Pigeon B 5/29/18 ID M Nestling 32 1034 
1957-41018 Dead Pigeon B 5/29/18 ID M Nestling 32 1098 
1967-06492 Moore's Road Central 6/01/18 ID F Nestling 36 1455 
1967-06493 Guzzler 6/01/18 ID F Nestling 29 1381 
1967-06494 Guzzler 6/01/18 ID F Nestling 29 1507 
1967-06495 Guzzler 6/01/18 ID F Nestling 28 1338 
1957-41019 Moore's Road Central 6/01/18 ID M Nestling 36 1007 
1957-41020 Moore's Road Central 6/01/18 ID M Nestling 36 1008 
1967-06496 Cabin 6/04/18 ID F Nestling 30 1374 
1967-06497 Cabin 6/04/18 ID F Nestling 30 1339 
1967-06798 Cabin 6/04/18 ID F Nestling 28 1383 
18WY7701 Buff ID 77 6/08/18 WY U Nestling 18 706 
1207-81379 Shadescale Exclosure 6/08/18 ID F Nestling 34 1295 
1207-81380 Shadescale Exclosure 6/08/18 ID F Nestling 32 1269 
1207-81381 Shadescale Exclosure 6/08/18 ID F Nestling 36 1423 
1207-81382 Big Baja 77-81 6/08/18 ID F Nestling 45 1625 
1207-81383 Moore's Road West 6/08/18 ID F Nestling 36 1349 
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Individual ID Nest ID Date  State Sex1 
Life 
Stage 
Age 
(d)  
Mass 
(g) 
1207-81384 Moore's Road West 6/08/18 ID F Nestling 32 1333 
1207-81385 Moore's Road West 6/08/18 ID F Nestling 36 1511 
1207-81386 Moore's Road West 6/08/18 ID F Nestling 34 1395 
1207-81387 Coyote Exclosure B 6/08/18 ID F Nestling 28 1136 
1207-81388 Coyote Exclosure B 6/08/18 ID F Nestling 28 1290 
1207-81389 Coyote Exclosure B 6/08/18 ID F Nestling 32 1301 
1957-31845 Shadescale Exclosure 6/08/18 ID M Nestling 36 946 
1957-31846 Tank Road 6/08/18 ID M Nestling 36 1007 
1957-31847 Tank Road 6/08/18 ID M Nestling 35 942 
1957-31848 Tank Road 6/08/18 ID M Nestling 33 947 
1957-31849 Tank Road 6/08/18 ID M Nestling 36 946 
1957-38150 Moore's Road West 6/08/18 ID M Nestling 32 1044 
1957-41039 Coyote Exclosure B 6/08/18 ID M Nestling 30 834 
1957-41040 Coyote Exclosure B 6/08/18 ID M Nestling 30 800 
18WYFH1B01 FH-1B 6/10/18 WY U Nestling 21 806 
18WYFH1B02 FH-1B 6/10/18 WY U Nestling 17 985 
18WYFH1B03 FH-1B 6/10/18 WY U Nestling 23 903 
18WY0702 Buff ID 7 6/10/18 WY F Nestling 26 1199 
1967-06499 FH-5 6/10/18 WY F Nestling 32 1542 
1967-06500 FH-5 6/10/18 WY F Nestling 28 1533 
18WY0703 Buff ID 7 6/10/18 WY M Nestling 24 732 
1957-41021 FH-5 6/10/18 WY M Nestling 32 1139 
1957-41022 FH-5 6/10/18 WY M Nestling 30 1167 
1207-82007 FH-6 6/11/18 WY F Nestling 31 1356 
1207-82008 FH-6 6/11/18 WY F Nestling 29 1429 
18WY0402 Buff ID 4 6/11/18 WY F Nestling 24 1329 
1967-03146 Tank Road 6/11/18 ID F Adult - 1999 
18WYFH701 FH-7 6/11/18 WY M Nestling 20 856 
18WYFH702 FH-7 6/11/18 WY M Nestling 19 851 
1957-41023 Buff ID 4 6/11/18 WY M Nestling 30 1096 
1957-41024 Buff ID 4 6/11/18 WY M Nestling 28 1091 
1957-41025 FH-6 6/11/18 WY M Nestling 31 1032 
18WYFH3802 FH-8 6/12/18 WY F Nestling 17 995 
18WYFH3803 FH-8 6/12/18 WY F Nestling 19 1053 
18WYFH3801 FH-8 6/12/18 WY M Nestling 21 851 
18WYFH2104 FH-21 6/13/18 WY U Nestling 24 885 
1088-09141 Bryan's Run 6/13/18 ID F Nestling 44 1621 
1207-81390 Moore's Road East 6/13/18 ID F Nestling 39 1494 
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Individual ID Nest ID Date  State Sex1 
Life 
Stage 
Age 
(d)  
Mass 
(g) 
1207-81391 Moore's Road East 6/13/18 ID F Nestling 36 1372 
1207-81393 Section 16 Farm 6/13/18 ID F Nestling 30 1330 
1207-81394 Henderson Draw 6/13/18 ID F Nestling 26 950 
1207-81395 Bryan's Run 6/13/18 ID F Nestling 44 1660 
1207-82009 Interstate 1 6/13/18 WY F Nestling 31 1432 
1207-82010 Interstate 1 6/13/18 WY F Nestling 28 1419 
1207-82011 FH-21 6/13/18 WY F Nestling 26 1295 
18WYINT301 Interstate 3 6/13/18 WY F Nestling 23 863 
18WYINT302 Interstate 3 6/13/18 WY F Nestling 24 914 
1207-81392 Section 16 Farm West 6/13/18 ID M Nestling 35 1323 
18WYINT303 Interstate 3 6/13/18 WY M Nestling 26 894 
1957-41026 Interstate 1 6/13/18 WY M Nestling 29 1039 
1957-41027 FH-21 6/13/18 WY M Nestling 26 991 
1957-41028 FH-21 6/13/18 WY M Nestling 26 937 
1957-41041 Big Baja 230 6/13/18 ID M Nestling 35 816 
1957-41042 Moore's Road East 6/13/18 ID M Nestling 35 839 
1957-41043 Moore's Road East 6/13/18 ID M Nestling 36 988 
1957-41044 Section 16 Farm West 6/13/18 ID M Nestling 34 1274 
1957-41045 Section 16 Farm West 6/13/18 ID M Nestling 33 971 
1957-41046 Section 16 Farm West 6/13/18 ID M Nestling 36 885 
1957-41047 Section 16 Farm 6/13/18 ID M Nestling 32 839 
1957-41048 Section 16 Farm 6/13/18 ID M Nestling 32 866 
1957-41049 Section 16 Farm 6/13/18 ID M Nestling 31 799 
1957-41050 Henderson Draw 6/13/18 ID M Nestling 26 803 
1957-41051 Henderson Draw 6/13/18 ID M Nestling 25 822 
1957-41052 Bryan's Run 6/13/18 ID M Nestling 44 1023 
1957-41053 Bryan's Run 6/13/18 ID M Nestling 44 991 
1957-41054 Bryan's Run 6/13/18 ID M Nestling 44 1055 
18WYWCC01 Wild Cow Camp 6/14/18 WY U Nestling 17 934 
1207-81396 Coyote South 6/14/18 ID F Nestling 34 1414 
1207-81397 Coyote Butte B 6/14/18 ID F Nestling 32 1471 
1207-81398 Coyote Butte A 6/14/18 ID F Nestling 42 1650 
1207-82012 FH-23 6/14/18 WY F Nestling 30 1360 
1207-82013 FH-23 6/14/18 WY F Nestling 31 1440 
1957-41029 FH-23 6/14/18 WY M Nestling 32 1018 
1957-41030 FH-23 6/14/18 WY M Nestling 31 1022 
1957-41055 Coyote South 6/14/18 ID M Nestling 35 927 
1957-41056 Coyote South 6/14/18 ID M Nestling 32 839 
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Individual ID Nest ID Date  State Sex1 
Life 
Stage 
Age 
(d)  
Mass 
(g) 
1957-41057 Coyote South 6/14/18 ID M Nestling 34 970 
1207-82014 FH-29 6/15/18 WY F Nestling 28 1364 
1207-82015 FH-29 6/15/18 WY F Nestling 30 1452 
18WYFH2901 FH-29 6/15/18 WY F Nestling 25 1234 
18WYFH3003 FH-30 6/15/18 WY F Nestling 26 1430 
18WYRED01 Red Desert 6/15/18 WY F Nestling 24 1269 
18WYFH3002 FH-30 6/15/18 WY M Nestling 20 890 
18WYRED02 Red Desert 6/15/18 WY M Nestling 25 911 
18WYRED03 Red Desert 6/15/18 WY M Nestling 22 925 
18WYRED04 Red Desert 6/15/18 WY M Nestling 27 943 
1957-41031 FH-30 6/15/18 WY M Nestling 28 1029 
1957-41032 FH-29 6/15/18 WY M Nestling 29 1113 
18WY5601 Buff ID 56 6/16/18 WY F Nestling 26 1219 
18WY6502 Buff ID 65 6/16/18 WY F Nestling 20 956 
18WY6503 Buff ID 65 6/16/18 WY F Nestling 21 955 
18WY6702 Buff ID 67 6/16/18 WY F Nestling 20 1214 
18WY6501 Buff ID 65 6/16/18 WY M Nestling 19 765 
18WY6701 Buff ID 67 6/16/18 WY M Nestling 24 844 
18WY6703 Buff ID 67 6/16/18 WY M Nestling 24 955 
18WYCL02 Chain Lakes 6/16/18 WY M Nestling 26 962 
1957-41033 Chain Lakes 6/16/18 WY M Nestling 31 1034 
1207-82016 Pathfinder 6/19/18 WY F Nestling 34 1620 
1957-41034 Pathfinder 6/19/18 WY M Nestling 34 1107 
1957-41035 Pathfinder 6/19/18 WY M Nestling 30 1053 
1207-82017 Jenga Rock 6/21/18 WY F Nestling 42 1545 
1207-82018 Jenga Rock 6/21/18 WY F Nestling 41 1558 
1957-41036 Jenga Rock 6/21/18 WY M Nestling 40 1066 
1207-82019 Windmill 1 6/25/18 WY F Nestling 42 1721 
1207-82020 Buff ID 2 6/25/18 WY F Nestling 29 1574 
18WYWIN02 Windmill 2 6/25/18 WY F Nestling 28 1295 
1957-31851 Windmill 1 6/25/18 WY M Nestling 40 1112 
1957-31852 Buff ID 2 6/25/18 WY M Nestling 30 1074 
1957-31853 Buff ID 2 6/25/18 WY M Nestling 31 1085 
1957-31854 Buff ID 2 6/25/18 WY M Nestling 31 1021 
1957-41037 Windmill 2 6/25/18 WY M Nestling 28 976 
1957-41038 Windmill 1 6/25/18 WY M Nestling 42 1130 
1207-82021 Sandstone City 6/26/18 WY F Nestling 31 1476 
1207-82022 Sandstone City 6/26/18 WY F Nestling 29 1426 
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1Presumptive sex (M = Male, F = Female) based on morphological measurements at time 
of capture. U = unknown sex. 
Individual ID Nest ID Date  State Sex1 
Life 
Stage 
Age 
(d)  
Mass 
(g) 
1207-82023 Buff ID 44 6/26/18 WY F Nestling 30 1410 
1957-31855 Sandstone City 6/26/18 WY M Nestling 30 1135 
1957-31856 Buff ID 44 6/26/18 WY M Nestling 32 1068 
1207-82024 Waltman 6/27/18 WY F Nestling 41 1552 
1957-31857 Waltman 6/27/18 WY M Nestling 40 1121 
1957-31858 Waltman 6/27/18 WY M Nestling 40 1028 
1957-31859 Nebo 6/27/18 WY M Nestling 31 1088 
1207-82025 Interstate 2 6/28/18 WY F Nestling 28 1372 
1207-82026 Mines 4  6/28/18 WY F Nestling 42 1528 
1207-82027 Mines 2 6/28/18 WY F Nestling 40 1489 
1207-82028 Mines 2 6/28/18 WY F Nestling 40 1395 
1207-82029 Buff ID 77 6/28/18 WY F Nestling 32 1549 
1207-82030 Buff ID 78 6/28/18 WY F Nestling 30 1354 
1957-31860 Interstate 2 6/28/18 WY M Nestling 28 1005 
1957-31861 Buff ID 76  6/28/18 WY M Nestling 32 952 
1207-82031 Pinedale 2 6/29/18 WY F Nestling 42 1644 
2207-01921 Cow Pasture 5/31/19 ID F Nestling 34 1497 
2207-01925 Surprise 6/02/19 ID F Nestling 40 1631 
2207-01944 Dead Pigeon B 6/11/19 ID F Nestling 40 1471 
19WYFH2701 FH-27 6/16/19 WY U Nestling 26 1240 
19COSSN01 SSN01 6/26/19 CO U Nestling 21 817 
2207-01959 Windmill 2 6/27/19 WY F Nestling 36 1466 
2187-04462 Jenga Rock 6/27/19 WY M Nestling 40 1126 
2207-01964 Pathfinder 6/29/19 WY F Nestling 30 1196 
2187-04465 Pacific 6/29/19 WY M Nestling 39 1090 
2207-01972 Pinedale 2 7/02/19 WY F Nestling 40 1586 
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Figure. A2.1 The random effect (intercept) of nest site on the estimated 
prothrombin time (PT).
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CHAPTER TWO: EVALUATING A RAPID FIELD ASSESSMENT SYSTEM FOR 
ANTICOAGULANT RODENTICIDE EXPOSURE OF RAPTORS 
Abstract 
Anticoagulant rodenticides (ARs) are compounds that are commonly used to 
control rodent pests by inhibiting an enzyme critical for clotting factor synthesis. 
Secondary and tertiary poisoning of non-target species frequently occurs, especially of 
predators. Raptors often hunt rodents, so secondary exposure to ARs is of conservation 
concern for many species of raptors. Indeed, post-mortem analysis of hepatic tissue from 
a large number of raptor species from around the world have revealed AR poisoning. 
Less understood is the prevalence of AR exposure and any possible sub-lethal effects in 
free-living raptor populations. Multiple point-of-care (POC) devices have been developed 
to measure PT and decrease costs incurred to human patients on anticoagulant drugs. I 
evaluated the potential of using one of these POC devices, the Coag-Sense® PT/INR 
Monitoring System manufactured by CoaguSense Inc. (Fremont, California), as a way to 
rapidly detect AR exposure in living birds of prey making use of small blood samples. 
The Coag-Sense® device delivered repeatable PT measurements on avian blood samples 
collected from four species of migrating raptors (Intraclass Correlation Coefficient >0.9). 
However, PT measurements reported by the Coag-Sense® system from 81 ferruginous 
hawk (Buteo regalis) nestlings were not correlated to those measured by standardized 
laboratory techniques (r = -0.017). The Coag-Sense® device therefore did not accurately 
measure PT in this species of bird and is unlikely to do so in other birds of prey. 
However, this device has potential use on non-human mammals.  
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Introduction 
Anticoagulant rodenticides (ARs) have a long, global history as an effective and 
successful pesticide. Anticoagulants have been the main choice for rodent pest 
management because of their effectiveness in controlling pest populations, affordability, 
and the readily available treatment with vitamin K in the case of accidental poisoning 
(Hadler and Buckle, 1992; Jacob and Buckle, 2018). In the 1970s, evolution of AR 
resistance in some rodents to “first generation” compounds propelled the development of 
“second generation anticoagulant rodenticides” or SGARs (Pelz et al., 2005). These 
newer compounds have higher potency, a greater affinity to binding sites in the liver, and 
a longer half-life (Laakso et al., 2010).  
ARs work by blocking a liver enzyme that is essential to the clotting factor 
synthesis cycle, depleting the level of clotting factors over time. The diminishing number 
of clotting factors subsequently increases clotting time, or prothrombin time (PT), to a 
point where hemorrhaging ensues (Rattner et al., 2010). This clotting mechanism is 
conserved among vertebrates, so ARs can have toxic effects on non-target species 
through secondary poisoning (Doolittle and Feng, 1987). The increased toxicity of 
SGARs exacerbates the negative effects on non-target wildlife, leading to conservation 
concern surrounding their use (Nakayama et al., 2019). 
Accumulation of ARs is usually measured within the liver of deceased animals 
using high-performance liquid chromatography (HPLC) with fluorescence UV detection 
and mass spectrometry and/or liquid chromatography with tandem mass spectrometry 
(LC/MS/MS; Vandenbroucke et al., 2008; Hindmarch et al., 2019; Nakayama et al., 
2019). Unfortunately, analysis of liver is only useful in post-mortem cases and therefore 
72 
 
 
cannot shed light on levels, timing or frequency of exposure in free-living wildlife, nor 
can it cast light on sub-lethal effects of AR exposure (Hindmarch et al., 2019). Analyzing 
AR concentrations in blood from living animals would be preferable, but such AR 
exposure assessments are challenging because they require large volumes of blood, they 
are expensive, and because ARs have a short half-life in blood. For example, ARs were 
detected in 94% of 24 livers but 0% of 10 blood samples in caracal (Caracal caracal) 
cats in South Africa (Serieys et al., 2019).  
Because of the challenges associated with detecting ARs in blood, some studies 
have used clotting time assays, such as PT, as a biomarker for AR exposure (Murray and 
Tseng, 2008; Rattner et al., 2010; Hindmarch et al., 2019). This is because when exposed 
to ARs, clotting time in birds of prey is prolonged in relative proportion to the amount of 
AR ingested (Rattner et al., 2010). This use of clotting time as a biomarker creates 
opportunity to adapt technologies developed in other fields to understand wildlife 
exposure to ARs. In fact, around the time that ARs were gaining popularity as a method 
to control rodent pests, the same compounds also became the main preventative and 
treatment option for blood clots in humans (Pelz et al., 2005). Warfarin was one of the 
first such drugs heavily used (Fuentes et al., 2018). This drug can cause adverse effects 
when out of therapeutic range, so patients must be closely monitored by regularly 
measuring their clotting or prothrombin time (Pirmohamed, 2006; Wells et al., 2007). 
This need for constant monitoring has fueled the development of point-of-care (POC) 
devices that allows patients to self-test and adjust their drug dosage accordingly 
(Pirmohamed, 2006; Wells et al., 2007).  
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These recently developed POC devices for humans may be a feasible and 
relatively inexpensive way to detect AR exposure in free-living wildlife under field 
conditions. Benefits from an easy to use AR rapid assessment system could include the 
ability to rapidly treat exposed birds in the field, collect data on possible sub-lethal 
effects, and be able to assay ARs in smaller birds for which the blood volumes needed for 
laboratory assessment of AR presence preclude their use. Such an approach has worked 
before. For instance, field scientists and wildlife rehabilitation centers working with sick 
or injured birds test them for lead exposure using a point-of-care testing system originally 
designed for humans, e.g., the LeadCare® device (Rodriguez-Ramos et al., 2009). 
Free-living raptors (birds of prey) are among the non-target species commonly 
exposed to ARs (Cox and Smith, 1992; EPA, 2017; van den Brink et al., 2018; 
Nakayama et al., 2019). Thus, my objective was to evaluate the potential use of a POC 
device originally developed for humans as a way to rapidly assess AR exposure in free-
living birds of prey. I had two research questions: 1) How precise are PT measurements 
in bird blood from a commercially available POC device originally developed for 
humans, and 2) how accurate are the PT measurements collected for avian samples from 
that same POC device.  
Methods 
Coag-Sense® PT/INR Monitoring System 
I used a Coag-Sense® PT/INR Monitoring System manufactured by CoaguSense 
Inc. (Fremont, California) and commercially available from Wilburn Medical USA 
(Kernersville, North Carolina) to measure the clotting response of free-living raptors 
(Fig. 2.1). The Coag-Sense® PT/INR Monitoring System is one of several POC 
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diagnostic devices that quantifies PT, measured in seconds, and the international 
normalized ratio (INR), which is unitless. INR is a standardized PT metric used to 
account for variation inherent in different reagents. INR incorporates an assigned 
International Sensitivity Index (ISI) metric for each thromboplastin. The ISI indicates 
how the particular thromboplastin compares to the international reference (Kitchen and 
Preston, 1999). INR is calculated as: 
𝐼𝑁𝑅 =   (
𝑃𝑇 (𝑝𝑎𝑡𝑖𝑒𝑛𝑡)
𝑃𝑇 (𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒)
)
𝐼𝑆𝐼  
 
INR is then used to adjust drug dosage for humans (Duxbury and Poller, 2001; 
Harris et al., 2013). According to the manufacturer’s user manual, the Coag-Sense® 
PT/INR Monitoring System has built-in quality control software to undergo self-checks 
every time the machine is powered on to ensure that the timing function, battery level, 
mechanical and optical functions can operate within specification. If there are any 
problems detected during this self-check, an error message will be displayed, and the 
device will not test the sample. The control software also assures performance accuracy 
during sample testing, such as controlling a heater to ensure that the temperature of each 
sample is consistent (Review Memorandum, 2018). Once inside the device, a blood 
sample is mixed with a recombinant rabbit thromboplastin reagent to activate clotting 
factors (Harris et al., 2013). The resultant clot blocks an infrared photosensor and the rate 
at which the sensor is blocked allows the unit to measure speed of clotting (Review 
Memorandum, 2018). INR is calculated from PT measurements, and the Coag-Sense® 
displays and stores both the PT and INR measurements for each sample.    
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Intra-Device Precision 
Before any quantitative instruments can be used for research or other clinical 
applications, their precision, or the extent that their measurements can be reproduced, 
should be evaluated (Koo and Li, 2016). To evaluate the precision of PT measurements 
from the Coag-Sense® PT/INR Monitoring System when using avian blood samples, I 
obtained and used two Coag-Sense® devices and evaluated samples collected from birds 
during Sept. – Oct. 2018 and 2019. Blood samples were collected from free-living raptors 
captured during fall migration at the Intermountain Bird Observatory’s Lucky Peak 
research station located near Boise, Idaho, USA (43°36’18” N, 116° 3’36” W). Hawks 
were trapped by station personnel using lures, mist nets, bow nets and Dho-gazza traps 
and then restrained, usually for < 30 min, in canisters until processed (Bloom et al., 
2007). During processing, morphometric measurements were collected, sex and age were 
estimated based on morphology and plumage, and each bird was given a uniquely 
numbered U.S. Geological Survey metal leg band. Subsequently, I pricked the bird’s 
wing vein with a 25-gauge needle and collected the pooled blood with two non-
heparinized microcapillary tubes, and then transferred the blood into two Coag-Sense® 
monitoring devices to measure clotting time and precision. I refer to the duplicate 
samples from an individual but measured by the two different devices as replicates 1 and 
2. 
Comparison of Prothrombin Time Estimates 
To address my second research question, I evaluated the accuracy of the 
measurements collected from the Coag-Sense® PT/INR Monitoring System using blood 
samples from free-living ferruginous hawk (Buteo regalis) nestlings. To do this, I 
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compared paired PT estimates of an individual derived from two different techniques: 
using the POC device in the field versus analyzing a citrated plasma sample using a 
standard and previously validated laboratory technique (Rattner et al., 2010). In contrast 
to the analysis using the POC device, the laboratory analysis used avian thromboplastin, 
rather than rabbit thromboplastin, to active the clotting cascade. Commercially available 
thromboplastins based on mammalian tissues are able to initiate the clotting cascade in 
avian blood samples and have shown potential promise for use in birds (Guddorf et al., 
2014).  
I collected blood samples from nestling hawks in southwestern Idaho, southern 
and central Wyoming, and northern Colorado (Fig. 2.2) during May – July 2019. I hand 
captured nestlings from their nests, restrained them in metal canisters, took 
morphological measurements (Hull and Bloom, 2001), estimated their age and sex 
(Moritsch, 1985; Gossett, 1993), and collected blood samples from the brachial vein of 
each bird (Monks and Forbes, 2007). First, I collected 0.9 ml of blood in a 1-ml syringe 
preloaded with 0.1 ml of 3.2% sodium citrate (i.e., a citrated sample; Hindmarch et al. 
2019). Immediately after the first sample was taken, I collected an additional 10 µl of 
blood from the same bird in a non-heparinized microcapillary tube and transferred it into 
the Coag-Sense® device. Then I transferred the citrated blood sample into a 1.5 ml-
microcentrifuge tube, gently inverted it several times, and stored it on ice until all of the 
nestlings at a site had been similarly sampled. I then centrifuged the citrated blood 
samples in the field at 2,000 x g for 10 min. The resultant plasma (usually 400 – 600 µl) 
was transferred into 1.2 ml cryovials using micropipettes and promptly frozen and stored 
inside a cryoshipper containing liquid nitrogen (Hindmarch et al., 2019). Cryovials were 
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transferred into a -80°C freezer upon returning from the field. The citrated plasma 
samples were shipped on dry ice to the Comparative Coagulation Laboratory in the 
Animal Health Diagnostic Center at Cornell University (Ithaca, NY) for analysis of PT 
according to the protocol by Rattner et al. (2010, Appendix 1). 
Statistical Analysis  
All statistical analyses were performed using R software version 3.5.1 (R Core 
Team, 2018). Normality of the data was confirmed with Shapiro-Wilk tests. To assess the 
precision of the POC device when measuring PT on avian blood samples, I calculated the 
intraclass correlation coefficient (ICC) for both the INR and PT measurements using a 
single-rating, absolute-agreement, two-way mixed effects model (Koo and Li, 2016) in 
the package “irr” (Gamer et al., 2019). 
To assess the accuracy of the Coag-Sense® measurements, I used a Pearson’s 
correlation analysis to examine the association between the paired PT measurements 
generated by the POC device and the standard laboratory technique. I also evaluated the 
null hypothesis that the mean difference between the paired PT measurements was zero. 
Because differences were not normally distributed, I employed the non-parametric 
Wilcoxon signed-rank test to examine the agreement between the two different methods. 
Finally, I calculated the coefficient of variation and compared the variability of the PT 
measurements estimated by each type of assay. I only used samples that did not have clot 
fragments present prior to analysis or had not hemolyzed during PT analysis. Means are 
given with standard deviations.   
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Results 
Intra-Device Precision 
I obtained replicate blood samples from six individuals of four migratory species: 
northern goshawk (Accipiter gentilis; n = 1), Cooper’s hawk (A. cooperi; n = 2), sharp-
shinned hawk (A. cooperii; n = 2), and merlin (Falco columbarius; n = 1; Table 2.1). The 
individuals I sampled included birds in their hatching year (HY, n = 3), second year (SY, 
n = 2), and older (after second year; ASY, n = 1), and individuals of both sexes were 
obtained (Table 2.1).  
There was a high degree of precision in the PT measurements collected by the two 
different Coag-Sense® devices with respect to the two replicates (Table 2.2; Fig 2.2; ICC 
> 0.9 indicate excellent repeatability; Koo and Li 2016). Similarly, INR values were also 
repeatable between the two devices (Table 2.2; ICC > 0.9).  
Comparison of Prothrombin Time Estimates 
I collected both citrated plasma and Coag-Sense® readings from 89 ferruginous 
hawk nestlings in 40 different nests. Eight samples either hemolyzed or had clot 
fragments present, which left 81 sample pairs suitable for analysis. There were 3 ± 1.0 
nestlings per nest (range: 1 – 5) of which I sampled 2 ± 1.0 (range 1 – 4). The sampled 
nestlings were 33 ± 6.3 d of age (n = 81), ranging from 19 – 42 d. Thirty-two (37%) of 
the ferruginous hawk nestlings analyzed were putative males, 34 (38%) were female, and 
15 (17%) were too young to predict sex.  
The accuracy of PT measurements, as defined above, collected by the Coag-
Sense® device was poor. PT measurements from the Coag-Sense® were, in nearly every 
instance, higher than those from the laboratory, and the mean difference (21.5 ± 13.8 sec, 
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n = 81) was significantly greater than zero (Wilcoxon signed-rank test: Z = 7.10, p < 
0.001).  Measurements collected from the Coag-Sense® device also had a larger range 
and were more variable overall compared to those from the laboratory (Table 2.3). 
Finally, there was no correlation between the PT estimates measured using the Coag-
Sense® system and those measured in the laboratory (Pearson’s correlation analysis: r = -
0.017, p = 0.88, n = 81, Fig.2.3). 
Discussion 
There is a clear need to develop methods for rapid assessment of AR exposure in 
birds because of an increased conservation concern surrounding the impacts of ARs on 
non-target wildlife, how much is still unknown about the sub-lethal effects of ARs, and 
the prevalence of AR exposure in raptor populations (Hindmarch et al., 2019; Serieys et 
al., 2019). Thus, I evaluated the ability of the Coag-Sense® PT/INR Monitoring System 
to precisely and accurately measure PT in avian blood samples as a biomarker for AR 
exposure. Although the device was precise, indicated by the high ICC value (Table 2.2) 
from replicate PT measurements, it turned out to be inaccurate. Overall, average PT 
measurements from the Coag-sense® device were substantially higher and more variable 
than measurements derived using standard laboratory techniques. Furthermore, the Coag-
sense® measurements did not correlate with the standard laboratory analyzed values. 
These results reveal that the use of the Coag-sense® system is unsuitable for rapidly 
assessing AR exposure in birds of prey.  
One potential explanation for these results is that the particular reagent within the 
device was not able to activate the clotting cascade as it would in human and possibly 
other mammalian species. The POC device I used relies on commercially available 
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reagents to activate the clotting cascade (Harris et al., 2013). Because these commercially 
available reagents are based on rabbit thromboplastin, they may not be suitable for avian 
blood, although they had shown some promise in previous studies (Guddorf et al., 2014). 
Avian thromboplastin is not commercially available because of its lack of stability and 
therefore most commercial laboratories do not have the means to assay avian PT (Doerr, 
1975; Webster et al., 2015). While not suitable for avian samples, the Coag-Sense® and 
other similar POC devices may be a great tool in rapidly assessing AR exposure in 
mammalian non-target wildlife (Guddorf et al., 2014). Specifically, one POC device, the 
CoaguChek®-XS, was shown to accurately and precisely measure PT in domestic dogs 
and horses (Newbould and Norman, 2013; Kelmer et al., 2014; Berlin et al., 2019).  
To better assess AR exposure in raptor populations, research paths could include 
evaluating other POC devices or modifying these POC devices to include a more suitable 
reagent to assess PT in avian samples. In this study, I only evaluated one type of POC 
device for avian use. There are currently 18 different POC devices available for human 
use, and these devices use varying methods to estimate PT (Harris et al., 2013).  In terms 
of modifying the device, changing the commercial reagent from rabbit to bovine 
thromboplastin may improve PT estimates from avian samples (Guddorf et al., 2014). An 
easily deployed methodology to assess AR exposure in field conditions would 
significantly improve our knowledge of the prevalence and effects in free-living raptor 
populations.   
Using PT measurements derived from standard laboratory techniques has been 
proposed as a way to assess AR exposure (Murray and Tseng, 2008; Rattner et al., 2010; 
Hindmarch et al., 2019). However, field collection of samples and subsequent analysis 
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pose challenges. Among the challenges is that collecting citrated plasma samples requires 
a precise 1:9 sodium citrate to whole blood ratio, and quick access to ultra-low 
temperatures to prevent sample degradation. Moreover, avian thromboplastin requires 
substantial effort and expertise to prepare (Guddorf et al., 2014). Six hours after 
preparation, avian thromboplastin begins to become unstable, leading to reduced activity 
and artificially prolonging PT estimates (Doerr et al., 1975; Morrisey et al., 2003). 
Hence, variation between laboratories arises between differences in methodologies and 
batches of thromboplastin. To reduce variation between laboratories, a standardized 
methodology needs to be employed or analysis should be conducted at a single laboratory 
(Hindmarch et al., 2019). To account for differences in thromboplastins, a metric that can 
be compared globally for wildlife may need to be implemented, such as how INR was 
established for human patients to standardize differences in reagents used globally. These 
challenges make measuring PT a difficult way to monitor AR exposure in wildlife on any 
wide scale basis and underscore the ongoing need for the development of a new way to 
rapidly assess AR exposure in birds of prey. 
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Tables 
Table 2.1 The species, age, sex and PT/INR measurements (replicate 1 and 2) to 
examine the repeatability of Coag-Sense® values in birds of prey 
captured near Boise, Idaho, USA. Age codes: HY = hatching year, SY 
= second year, ASY = after second year. 
1See text for scientific name. 
 
 
    INR  PT (sec) 
Year Species1 Age Sex Rep 1 Rep 2  Rep 1 Rep 2 
2018 Sharp-shinned hawk  SY M 5.8 5.9  75.0 73.0 
2018 Northern goshawk HY M 3.2 3.2  39.5 39.6 
2018 Sharp-shinned hawk  ASY F 4.1 4.3  52.0 55.4 
2018 Cooper's hawk SY M 3.0 3.5  37.0 44.2 
2019 Cooper's hawk HY F 3.5 3.9  38.4 43.1 
2019 Merlin HY F 2.0 2.1  23.4 25.8 
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Table 2.3  Summary of prothrombin time (PT) estimates in seconds for 
ferruginous hawk nestlings (n = 81) from Idaho, Wyoming and 
Colorado in 2019. Estimates were derived from using the Coag-Sense® 
monitoring system in the field and from using standard laboratory 
techniques (see text).  
1Coefficeient of variation 
 
  
Method Mean PT  Median PT  Range  Std. Deviation CV1 
Laboratory 29.8 29.2 21.3 - 41.2 4.82 16.2 % 
Coag-Sense® 49.2 50.0 13.10 - 88.8 15.82 32.2 % 
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Figures 
 
Figure 2.1  The Coag-Sense® PT/INR Monitoring System. Once a strip is 
inserted correctly and the device calibrates for 30 seconds, a 10 µl blood sample can 
be placed onto the strip (A). The Coag-Sense® then measures and displays 
prothrombin time (PT) and international normalized ratio (INR) for a sample (B).
A B 
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Figure 2.2  Location of ferruginous hawk nests where blood sampling for 
the measurement of prothrombin time (PT) and international normalized ratio 
(INR) was conducted in Idaho, Wyoming, and Colorado in the western United 
States during 2019.  
  
 Idaho 
Colorado 
Wyoming 
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Figure 2.3 Prothrombin time (PT) estimates in migrating birds of prey (n 
= 6 individuals of 4 species, see Table 2.1) calculated using two different Coag-
Sense® devices using samples derived from the same individual. (Replicate 1 and 2). 
Box plots show median, interquartile range, and the minimum and maximum for 
each replicate. 
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Figure 2.4  Relationship between prothrombin time (PT) estimates in 
nestling ferruginous hawks obtained from the Coag-Sense® system in the field and 
those using standard techniques as described by Rattner et al. (2010) in a laboratory 
(Pearson’s correlation analysis: r = -0.017, p = 0.88, n = 81) on samples obtained 
from the same individual in rapid succession while in the field. 
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